Ammonia Metabolism and Toxicity — MCQs
Which of the following statements about carbamoyl phosphate synthase is incorrect?
Because free ammonia in the blood is toxic to the body, it is transported in which of the following non-toxic forms?
Ammonia is detoxified in brain to :
A newborn presents with metabolic acidosis, high ammonia, and orotic acid in urine. Which enzyme deficiency is most likely?
Glutamine is increased in CSF, blood & urine WITHOUT elevated orotic acid in which defect:
What is the diagnosis in a patient who presents with nausea and vomiting, initially responds to intravenous glucose, but later develops increased blood glutamine and orotic acid levels?
Most common enzyme deficiency in the urea cycle is:
Which defect in the urea cycle is an X-linked disease?
A patient with chronic liver disease presents with confusion and asterixis. Ammonia levels are elevated. Diagnosis?
A 2-month-old infant presents with vomiting, lethargy, and metabolic acidosis. Blood tests reveal elevated levels of ammonia. What is the most likely diagnosis?
Ammonia Metabolism and Toxicity Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following statements about carbamoyl phosphate synthase is incorrect?
- A. Requires biotin as a cofactor (Correct Answer)
- B. Enzyme found in the cytosol
- C. Enzyme found in mitochondria
- D. Catalyzes a condensation reaction
Explanation: ***Requires biotin as a cofactor*** - This is the **incorrect** statement and therefore the correct answer to this question. - Carbamoyl phosphate synthase (both CPS I and CPS II) does **NOT require biotin** as a cofactor. - Biotin is a cofactor for **carboxylase enzymes** such as pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and methylcrotonyl-CoA carboxylase. - Carbamoyl phosphate synthase requires **ATP** and **Mg²⁺** but not biotin. *Enzyme found in mitochondria* - This statement is **correct**. - **Carbamoyl phosphate synthase I (CPS I)** is located in the **mitochondrial matrix** and catalyzes the first step of the urea cycle. - CPS I uses free ammonia (NH₃) as the nitrogen source and is activated by N-acetylglutamate. *Enzyme found in the cytosol* - This statement is **correct**. - **Carbamoyl phosphate synthase II (CPS II)** is located in the **cytosol** and is involved in de novo pyrimidine biosynthesis. - CPS II uses the amide nitrogen of glutamine (not free ammonia) as the nitrogen source. *Catalyzes a condensation reaction* - This statement is **correct**. - Both CPS I and CPS II catalyze the condensation of CO₂ (as bicarbonate), ammonia/glutamine, and two molecules of ATP to form carbamoyl phosphate, 2 ADP, and inorganic phosphate. - This is a complex reaction involving phosphorylation and condensation steps.
Question 2: Because free ammonia in the blood is toxic to the body, it is transported in which of the following non-toxic forms?
- A. Glutamine and urea
- B. Alanine and glutamine (Correct Answer)
- C. Phenylalanine and methionine
- D. Histidine and urea
Explanation: ***Alanine and glutamine*** - **Glutamine** is the primary transporter of ammonia from most peripheral tissues to the liver and kidneys, where it can be safely released and processed. - **Alanine** transports ammonia from muscles to the liver via the glucose-alanine cycle, allowing for hepatic urea synthesis and glucose production. *Glutamine and urea* - While **glutamine** is a major ammonia transporter, **urea** is the *end product* of ammonia detoxification and is primarily synthesized in the liver for excretion. - Urea itself is not a transport form of ammonia *within* the blood before its synthesis; rather, it is the waste product. *Phenylalanine and methionine* - **Phenylalanine** and **methionine** are essential amino acids involved in protein synthesis and various metabolic pathways. - They do not serve as significant carriers for the transport of toxic free ammonia in the bloodstream. *Histidine and urea* - **Histidine** is an amino acid involved in protein synthesis and histamine production, but not primarily in ammonia transport. - As mentioned, **urea** is the final excretory form of detoxified ammonia, not a transport form within the blood.
Question 3: Ammonia is detoxified in brain to :
- A. Urea
- B. GABA
- C. Glutamine (Correct Answer)
- D. Uric acid
Explanation: ***Glutamine*** - In the brain, **ammonia** is primarily detoxified through its conversion into **glutamine** by the enzyme **glutamine synthetase**. - This process is crucial for preventing **neurotoxicity** as ammonia can disrupt neuronal function and energy metabolism. *Urea* - **Urea** is the primary end product of **ammonia detoxification** in the **liver** through the **urea cycle**. - While urea can cross the blood-brain barrier, it is not the main mechanism for local ammonia detoxification within brain cells. *GABA* - **GABA (gamma-aminobutyric acid)** is an **inhibitory neurotransmitter** formed from **glutamate**. - It plays a vital role in neuronal signaling but is not directly involved in the detoxification of ammonia in the brain. *Uric acid* - **Uric acid** is the end product of **purine metabolism** and acts as an antioxidant. - It is not directly involved in the detoxification pathway of ammonia in the brain or any other organ.
Question 4: A newborn presents with metabolic acidosis, high ammonia, and orotic acid in urine. Which enzyme deficiency is most likely?
- A. Arginase
- B. Glutamine synthetase
- C. Ornithine transcarbamylase (Correct Answer)
- D. CPS-1
Explanation: ***Ornithine transcarbamylase*** - Deficiency of **ornithine transcarbamylase (OTC)**, a key enzyme in the urea cycle, leads to the accumulation of **carbamoyl phosphate**. - **Carbamoyl phosphate** is then shunted to the pyrimidine synthesis pathway, leading to increased production and excretion of **orotic acid** in the urine, along with **hyperammonemia** and **metabolic acidosis**. *Arginase* - **Arginase deficiency** in the urea cycle primarily causes increased **arginine levels** and **hyperammonemia**, but it does not typically lead to the accumulation of orotic acid. - The effects are often more chronic with gradual onset of symptoms, rather than severe neonatal presentation with orotic aciduria. *Glutamine synthetase* - **Glutamine synthetase** catalyzes the synthesis of glutamine from glutamate and ammonia, playing a crucial role in **ammonia detoxification**. - A deficiency would impair ammonia detoxification and lead to **hyperammonemia**, but it would not directly cause **orotic aciduria**. *CPS-1* - **Carbamoyl phosphate synthetase I (CPS-1)** deficiency is the first step of the urea cycle and leads to severe **hyperammonemia** due to the inability to form carbamoyl phosphate. - Unlike OTC deficiency, **CPS-1 deficiency** does not involve the buildup of carbamoyl phosphate; hence, **orotic acid levels** would be low or normal, not high.
Question 5: Glutamine is increased in CSF, blood & urine WITHOUT elevated orotic acid in which defect:
- A. Arginase
- B. Argininosuccinate lyase deficiency
- C. CPS-I (Correct Answer)
- D. Arginosuccinate synthetase
- E. OTC
Explanation: ***CPS-I*** - A deficiency in **Carbamoyl Phosphate Synthetase I (CPS-I)** leads to a severe block in the **urea cycle**, resulting in profound hyperammonemia. - The elevated ammonia is then shunted to produce more **glutamine** (via glutamine synthetase), which serves as a detoxification mechanism but also causes high levels of glutamine in CSF, blood, and urine. *Arginase* - **Arginase deficiency** primarily leads to elevated **arginine** levels and mild to moderate hyperammonemia, but not typically a dramatic increase in glutamine due to the block occurring later in the cycle. - Clinical features include progressive spasticity, growth retardation, and intellectual disability. *Argininosuccinate lyase deficiency* - This deficiency causes accumulation of **argininosuccinate** in body fluids, which is a diagnostic marker, rather than primarily increased glutamine. - It presents with severe hyperammonemia, neurological symptoms, and often hepatomegaly. *Arginosuccinate synthetase* - A deficiency in **argininosuccinate synthetase** (also known as citrullinemia type I) leads to a buildup of **citrulline** and severe hyperammonemia. - While hyperammonemia can indirectly increase glutamine, the primary diagnostic marker is elevated citrulline, and the glutamine increase is not as pronounced or directly symptomatic as in CPS-I deficiency. *OTC* - **Ornithine Transcarbamylase (OTC) deficiency** is the most common urea cycle disorder and leads to severe hyperammonemia, accompanied by elevated **orotic acid** due to carbamoyl phosphate shunting to pyrimidine synthesis. - While hyperammonemia drives glutamine synthesis, the presence of elevated orotic acid is a key differentiator from CPS-I deficiency, which does not have increased orotic acid.
Question 6: What is the diagnosis in a patient who presents with nausea and vomiting, initially responds to intravenous glucose, but later develops increased blood glutamine and orotic acid levels?
- A. CPS-I deficiency
- B. Arginino succinate synthetase deficiency
- C. CPS-II deficiency
- D. Ornithine transcarbamoylase deficiency (Correct Answer)
Explanation: ***Ornithine transcarbamoylase deficiency*** - **Ornithine transcarbamoylase (OTC) deficiency** is an X-linked urea cycle disorder that leads to the accumulation of **carbamoyl phosphate**. - This excess carbamoyl phosphate is shunted into pyrimidine synthesis, resulting in increased **orotic acid** and **glutamine** levels, and symptoms like nausea and vomiting due to hyperammonemia. *CPS-I deficiency* - **Carbamoyl phosphate synthetase I (CPS-I) deficiency** also causes hyperammonemia but does not involve elevated **orotic acid**, as the pathway leading to pyrimidine synthesis is not overstimulated. - This deficiency would present with high ammonia and glutamine levels, but **normal or low orotic acid**. *Arginino succinate synthetase deficiency* - **Argininosuccinate synthetase deficiency** (citrullinemia) is characterized by very high plasma **citrulline** levels, which are not mentioned in this patient's presentation. - While it is a urea cycle disorder causing hyperammonemia, the diagnostic marker of elevated citrulline differentiates it from OTC deficiency. *CPS-II deficiency* - **Carbamoyl phosphate synthetase II (CPS-II)** is involved in *de novo* pyrimidine synthesis and is not part of the urea cycle. - A deficiency in CPS-II would typically lead to **pyrimidine starvation** rather than hyperammonemia or elevated orotic acid.
Question 7: Most common enzyme deficiency in the urea cycle is:
- A. Ornithine transcarbamoylase (OTC) deficiency (Correct Answer)
- B. Arginase deficiency
- C. Carbamoyl phosphate synthase I deficiency
- D. Argininosuccinate synthetase deficiency
Explanation: ***Ornithine transcarbamoylase (OTC)*** - **OTC deficiency** is the most common and often the most severe inherited disorder of the **urea cycle**, leading to a buildup of ammonia. - It is an **X-linked recessive** disorder, predominantly affecting males, though carrier females can also exhibit symptoms. *Arginase deficiency* - This deficiency affects the final step of the urea cycle, leading to the accumulation of **arginine** and its precursors. - It is less common than OTC deficiency and typically presents with a later onset and milder symptoms. *Carbamoyl phosphate synthase I deficiency* - **CPS I deficiency** is a severe form of urea cycle disorder but is less common than OTC deficiency. - It results in the inability to synthesize **carbamoyl phosphate**, a crucial substrate for the urea cycle, leading to severe hyperammonemia. *Argininosuccinate synthetase deficiency* - This deficiency, also known as **citrullinemia type I**, leads to the accumulation of **citrulline** in the blood. - While it is a significant urea cycle disorder, it is not as frequently encountered as OTC deficiency.
Question 8: Which defect in the urea cycle is an X-linked disease?
- A. Ornithine transcarbamylase (Correct Answer)
- B. Arginase
- C. Argininosuccinate synthase
- D. Carbamoyl phosphate synthetase I
Explanation: ***Ornithine transcarbamylase*** - **Ornithine transcarbamylase (OTC) deficiency** is the only **X-linked recessive** disorder among the urea cycle defects. - Males are usually more severely affected, while females can be symptomatic carriers. *Carbamoyl phosphate synthetase I* - **Carbamoyl phosphate synthetase I (CPS1) deficiency** is an **autosomal recessive** disorder. - It is one of the more severe urea cycle defects, leading to profound hyperammonemia. *Arginase* - **Arginase deficiency** (hyperargininemia) is an **autosomal recessive** disorder. - It typically presents with a distinct neurological phenotype, including spasticity and developmental delay. *Argininosuccinate synthase* - **Argininosuccinate synthase deficiency**, also known as **Citrullinemia type I**, is an **autosomal recessive** disorder. - It leads to the accumulation of **citrulline** and **ammonia** in the blood.
Question 9: A patient with chronic liver disease presents with confusion and asterixis. Ammonia levels are elevated. Diagnosis?
- A. Subdural hematoma
- B. Wernicke's encephalopathy
- C. Hepatic encephalopathy (Correct Answer)
- D. Alcohol withdrawal
Explanation: ***Hepatic encephalopathy*** - **Confusion**, **asterixis**, and elevated **ammonia levels** in a patient with chronic liver disease are classic signs of hepatic encephalopathy [1]. - The liver's inability to metabolize toxins, particularly ammonia, leads to their accumulation in the brain, causing neurological dysfunction [1]. *Subdural hematoma* - While it can cause confusion, it typically presents after a **head injury** and is not directly linked to elevated ammonia levels or chronic liver disease. - Would likely be accompanied by focal neurological deficits or signs of increased intracranial pressure. *Wernicke's encephalopathy* - Characterized by the triad of **oculomotor dysfunction**, **ataxia**, and **confusion**, usually due to thiamine deficiency in chronic alcoholics [2]. - It is not directly associated with elevated ammonia levels as a primary cause. *Alcohol withdrawal* - Symptoms range from tremors and anxiety to seizures and delirium tremens, often with **autonomic hyperactivity**. - While common in patients with liver disease, elevated ammonia is not the primary diagnostic marker, and asterixis is not a hallmark symptom.
Question 10: A 2-month-old infant presents with vomiting, lethargy, and metabolic acidosis. Blood tests reveal elevated levels of ammonia. What is the most likely diagnosis?
- A. Urea Cycle Disorder (Correct Answer)
- B. Phenylketonuria
- C. Galactosemia
- D. Maple Syrup Urine Disease
Explanation: ***Urea Cycle Disorder*** - The combination of **vomiting**, **lethargy**, metabolic acidosis, and **elevated ammonia** in a 2-month-old infant is highly indicative of a urea cycle disorder due to the impaired detoxification of ammonia. - **Ammonia is neurotoxic**, explaining the lethargy, and its accumulation leads to severe metabolic derangements. *Phenylketonuria* - Characterized by the inability to metabolize **phenylalanine**, leading to its accumulation and neurological damage. - While it can cause developmental delay and seizures, it typically does **not present with acute metabolic acidosis** or hyperammonemia in infancy. *Galactosemia* - An inherited disorder of **galactose metabolism** that can cause vomiting, lethargy, and liver dysfunction, but is typically associated with **jaundice**, hepatomegaly, and **reducing substances in urine**, not primarily hyperammonemia and metabolic acidosis as the presenting features. - The primary defect is in the conversion of galactose to glucose, not ammonia detoxification. *Maple Syrup Urine Disease* - A rare metabolic disorder caused by a defect in the metabolism of **branched-chain amino acids** (leucine, isoleucine, valine). - Presents with feeding difficulties, lethargy, and a characteristic **sweet-smelling urine** ("maple syrup" odor), which is not mentioned in this case.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free